An accomplished courtroom advocate and counselor to management teams and boards of directors, Robert helps life sciences companies of all sizes navigate business conflicts. His industry knowledge, legal experience, and education through a B.S.E. and M.S.E. in biomedical engineering enable Robert to guide companies through all manner of patent, trade secret and commercial disputes.
Before litigation begins, Robert counsels clients on litigation threats surrounding product launches, generic or biosimilar challenges, failed collaborations, contractual breaches, and trade secret misappropriation.
Robert’s courtroom experience crosses trial and appellate courts throughout the United States and the Patent Trial and Appeal Board. And, he has advised clients on cross-border litigation strategies involving multiple U.S. and foreign jurisdictions. He has litigated disputes in technologies across the life sciences industry, including small molecules, biologics, gene therapy, medical devices, and software. Such litigations include “bet the company” actions against commercial rivals, Hatch-Waxman and BPCIA actions against generic/biosimilar challengers, and disputes with investors and licensing partners, among others.
Robert’s clients and engagements span the spectrum of large multinationals, including UCB, Loxo Oncology (an Eli Lilly company), Pfizer, Novo Nordisk, Google and Abiomed, through emerging and startup companies, such as AnaptysBio, Avalyn Pharma, Melinta Therapeutics, Passage Bio, and Sutro Biopharma.
Dedicated to pro bono service, Robert has negotiated IP licenses and research grants on behalf of an international research foundation and represented children seeking special education services.
Regularly recognized for his accomplishments, Robert has been repeatedly recognized for his patent litigation practice by The Legal 500 and Super Lawyers. He was also previously named one of the nation’s top five life sciences lawyers under 40 by Law360.
Robert is a member of the Alumni Advisory Board for the College of Engineering for the University of Michigan, where he provides guidance and input on strategic initiatives for the College.